|
Volumn 116, Issue 4, 2002, Pages 920-922
|
Adoptive therapy with monocyte-derived macrophages in the setting of high-dose chemotherapy and peripheral blood stem cell transplantation
|
Author keywords
Chemotherapy; Complications; Immunotherapy; Macrophages; Peripheral blood stem cell transplantation
|
Indexed keywords
ANTIINFECTIVE AGENT;
CARBOPLATIN;
CYTOKINE;
ETOPOSIDE;
GRANULOCYTE COLONY STIMULATING FACTOR;
IFOSFAMIDE;
ANTIMICROBIAL ACTIVITY;
ARTICLE;
AUTOTRANSPLANTATION;
CELL MATURATION;
CHEMOTHERAPY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOKINE PRODUCTION;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
HUMAN CELL;
LYMPHOMA;
MACROPHAGE;
MONONUCLEAR CELL;
PERIPHERAL BLOOD STEM CELL;
PRIORITY JOURNAL;
SECRETORY CELL;
SIDE EFFECT;
SOLID TUMOR;
ADOPTIVE TRANSFER;
ANTINEOPLASTIC AGENTS;
CASE-CONTROL STUDIES;
COMBINED MODALITY THERAPY;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
LYMPHOMA;
MACROPHAGES;
PILOT PROJECTS;
TRANSPLANTATION CONDITIONING;
TRANSPLANTATION, AUTOLOGOUS;
|
EID: 0036122737
PISSN: 00071048
EISSN: None
Source Type: Journal
DOI: 10.1046/j.0007-1048.2002.03377.x Document Type: Article |
Times cited : (2)
|
References (10)
|